HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hulya Yilmaz Selected Research

Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)

3/2007Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis.
10/2004Angiotensin-converting enzyme I/D gene polymorphisms and effects of left ventricular hypertrophy in Turkish myocardial infarction patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hulya Yilmaz Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
12/2011 - 05/2004
3Myocardial Infarction
10/2008 - 10/2004
3Diabetes Mellitus
06/2007 - 03/2004
2Inflammation (Inflammations)
12/2011 - 06/2007
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2006 - 01/2005
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2004 - 03/2004
1Autoimmune Diseases (Autoimmune Disease)
11/2020
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2020
1Chronic Disease (Chronic Diseases)
11/2020
1Insulin Resistance
12/2011
1Disease Progression
11/2009
1Purpura
11/2009
1Lung Neoplasms (Lung Cancer)
02/2009
1Hepatolenticular Degeneration (Wilson's Disease)
01/2009
1Hypertension (High Blood Pressure)
01/2009
1Atrial Fibrillation
10/2008
1Colorectal Neoplasms (Colorectal Cancer)
07/2007
1Chronic Kidney Failure (Chronic Renal Failure)
06/2007
1Neoplasm Metastasis (Metastasis)
03/2007
1Neoplasms (Cancer)
03/2007
1Prostatic Neoplasms (Prostate Cancer)
03/2007
1Acute Kidney Injury (Acute Renal Failure)
01/2007
1Glioma (Gliomas)
05/2006
1Meningioma (Meningiomas)
05/2006
1Cardiovascular Diseases (Cardiovascular Disease)
06/2004
1Vascular Diseases (Vascular Disease)
06/2004

Drug/Important Bio-Agent (IBA)

4Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
07/2007 - 03/2004
3LipidsIBA
01/2005 - 05/2004
2Aryldialkylphosphatase (Paraoxonase)IBA
11/2009 - 05/2004
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2007 - 10/2004
2Cholesterol Ester Transfer ProteinsIBA
01/2005 - 06/2004
2Lipoproteins (Lipoprotein)IBA
01/2005 - 06/2004
1Inosine Triphosphate (ITP)IBA
11/2020
1Rosiglitazone (Avandia)FDA Link
12/2011
1BiguanidesIBA
12/2011
1Pharmaceutical PreparationsIBA
12/2011
1Metformin (Glucophage)FDA LinkGeneric
12/2011
1ThiazolidinedionesIBA
12/2011
1Sepharose (Agarose)IBA
02/2009
1Superoxide DismutaseIBA
02/2009
1valylvaline (Val-Val)IBA
02/2009
1ApolipoproteinsIBA
01/2009
1RelaxinIBA
01/2009
1C-Reactive ProteinIBA
10/2008
1Oxidants (Oxidizing Agents)IBA
06/2007
1Malondialdehyde (Propanedial)IBA
06/2007
1Interleukin-8 (Interleukin 8)IBA
06/2007
1Glutathione (Reduced Glutathione)IBA
06/2007
1AntioxidantsIBA
06/2007
1Prostate-Specific Antigen (Semenogelase)IBA
03/2007
1Biomarkers (Surrogate Marker)IBA
03/2007
1Apolipoproteins E (ApoE)IBA
01/2007
1Apolipoprotein E4IBA
01/2007
1HomocysteineIBA
01/2006
1HDL CholesterolIBA
06/2004
1Triglycerides (Triacylglycerol)IBA
06/2004
1CholesterolIBA
06/2004
1oxidized low density lipoproteinIBA
06/2004
1human PON1 proteinIBA
05/2004

Therapy/Procedure

1Renal Dialysis (Hemodialysis)
06/2007
1Aftercare (After-Treatment)
03/2007
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2007